– New data from the HuMAIN study, which met the primary endpoint of weight loss and several efficacy and pharmacodynamic secondary endpoints, will be presented in a Late Breaking Clinical...

Data recently presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer Treatment with Annamycin results in statistically significant...

Aulisa® Medical USA, Inc., a Palo Alto, CA-based pioneer in FDA-cleared wearable, wireless, app-enabled continuous vital sign monitoring and remote patient monitoring technology with alarm...

Rigorous evaluation certifies the superior quality of health information exchange and the highest standards of privacy and security. ROCKVILLE, Md., Sept. 23, 2024 /PRNewswire/ -- Secure Exchange...

̶ Data From Narcolepsy Type 2 Cohort of ALKS 2680 Phase 1b Study to be Presented in Oral Presentation ̶ ̶ Data From Idiopathic Hypersomnia Cohort of ALKS 2680 Phase 1b Study Accepted for Poster...